Skip to content

Evaluating the Effectiveness of a New Way of Organizing Primary Health Care to Improve the Management of Alzheimer's Disease

Evaluating the Effectiveness of a New Way of Organizing Primary Health Care to Improve the Management of Alzheimer's Disease EvaMMADom

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03360552
Acronym
EvaMMADom
Enrollment
320
Registered
2017-12-04
Start date
2019-01-16
Completion date
2026-01-15
Last updated
2021-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease

Brief summary

The objective of the present study is to evaluate the effectiveness of a general practitioner (MG) management strategy guided by a multidimensional evaluation on the multidimensional score of fragility of patients with mild to moderately severe dementia, compared to those currently implemented (without the provision of such an assessment). The measurement of the respective effectiveness of the two types of care in primary care will itself be based on a multidimensional evaluation performed independently in the memory center having established the diagnosis of Alzheimer's disease. The secondary objectives are the evaluation of the impact of the strategy on the functional abilities of patients, the incidence of geriatric syndromes, cognitive functions, quality of life of the patient and the burden of the primary caregiver. The efficiency of the strategy will be assessed through a cost-effectiveness analysis. A survey of opinions will also be conducted among primary health care providers, carers and CMs on the implemented system.

Interventions

OTHERMultidimensional fragility index questionnaire RAI-Home Care

Questionnaire for assessing deficits in Alzheimer's disease

OTHERUsual care

Usual clinical evaluation

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with probable Alzheimer's disease, according to the criteria usually used in memory centers * Aged over 64 years with mild to moderately severe dementia syndrome * Volunteers for medical follow-up for a period of 20 months; Which the general practitioner attending agrees to participate in the research

Exclusion criteria

* Patients under 65 years old * presenting with early cognitive decline or severe dementia * Not meeting the clinical diagnostic criteria for Alzheimer's disease * Refusing or unable to sign informed consent to participate * Not voluntary for medical follow-up for a period of 20 months * Whose general practitioner refuses to participate in the research

Design outcomes

Primary

MeasureTime frameDescription
Assessment of multidimensional fragility scores20 monthsThe multidimensional evaluation score produced by Nurses in the home of AM patients and passed on to patients' doctors increases decision-making and patient care

Countries

France

Contacts

Primary ContactMattieu CECCALDI, PU-PH
mathieu.ceccaldi@ap-hm.fr491385928
Backup ContactJean-Olivier ARNAUD, Director
drci@ap-hm.fr491381475

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026